Global COPD and Asthma Devices Market


Posted October 1, 2018 by Prity1

Global COPD and Asthma Devices Market to reach $27,465.1 Millions by 2022, growing at a CAGR of 5.2% during 2016 – 2022. The global asthma and COPD drug market is a multi-billion dollar market which has a history of several decades.

 
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would continue till 2022, growing at a CAGR of 6.5% during the forecast period. The Europe market is expected to reach a market size of $ 7,419.8 Million by 2022. The North America market would witness the high growth rate of 3.3 % during 2016-2022.

The Metered Dose Inhalers (MDIs) market dominated the Global COPD and Asthma Inhaler Market in 2015 and would continue till 2022 growing at a CAGR of 4.2 % during the forecast period. The Soft Mist Inhalers (SMIs) market is expected to reach a market size of $ 10,663.1 Million by 2022. The Dry Powder Inhalers (DPIs) market would witness the high growth rate of 7.4 % during 2016-2022.

The US market dominated the North America COPD and Asthma Metered Dose Inhalers (MDIs) Market in 2015 and would continue till 2022. The Canada market would witness the growth rate of 3.7% during 2016-2022.
The report highlights the adoption of COPD and Asthma Devices worldwide. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

Full report: https://kbvresearch.com/global-copd-and-asthma-devices-market/

Research Scope
The market is segmented based on product type and geography.

Global COPD and Asthma Devices, By Product Type
Global COPD and Asthma Devices Market
Global COPD and Asthma Inhaler Market
Global COPD and Asthma Dry Powder Inhalers (DPIs) Market
Global COPD and Asthma Metered Dose Inhalers (MDIs) Market
Global COPD and Asthma Soft Mist Inhalers (SMIs) Market
Global COPD and Asthma Nebulizer Market
Global COPD and Asthma Pneumatic Nebulizers Market
Global COPD and Asthma Ultrasonic Nebulizer Market
Global COPD and Asthma Mesh Nebulizer Market
Global COPD and Asthma Devices Market, By Geography
North America
U.S
Mexico
Canada
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Related Reports:

North America COPD and Asthma Devices Market

Europe COPD and Asthma Devices Market

Asia Pacific COPD and Asthma Devices Market

LAMEA COPD and Asthma Devices Market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By KBV Research
Phone +916466616066
Business Address 244 Fifth Avenue, Suite 1407 , N.Y.
Country United States
Categories Health
Tags global copd and asthma devices market , global copd and asthma devices market competition , global copd and asthma devices market growth , global copd and asthma devices market size
Last Updated October 1, 2018